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To analyze HIV-1 genes in a nonhuman primate model for lentivirus infection and AIDS, recombinant SIV/HIV-1 (SHIV) clones
were constructed from two HIV-1 subtype-A isolates (HIV-1SF170 and HIV-1Q23–17 from individuals in Africa) and two HIV-1 subtype-E
isolates (HIV-19466 and HIV-1CAR402 from AIDS patients in Thailand and Africa), respectively. These four SHIV clones, designated
SHIV-A-170, SHIV-A-Q23, SHIV-9466.33, and SHIV-E-CAR, contain envelope (env) genes from the subtype-A or -E viruses.
Interestingly, SHIV-A-170, SHIV-A-Q23, and SHIV-9466.33 were restricted for replication in cultures of macaque lymphoid cells,
whereas SHIV-E-CAR replicated efficiently in these cells. Additional studies to define the block to replication in macaque cells were
focused on the subtype-E clone SHIV-9466.33. A SHIV intragenic env clone, containing sequence-encompassing V1/V2 regions of
HIV-1CAR402 and V3/V4/V5 regions of SHIV-9466.33, infected and replicated in macaque lymphoid cells. These results indicated that
the sequence-encompassing V1/V2 region of HIV-19466 was responsible for the block of the SHIV-9466.33 replication in macaque
cells. Analysis of viral DNA in acutely infected macaque cells revealed that SHIV-9466.33 was blocked at a step at/or before viral
DNA synthesis, presumably during the process of virion entry into cells. In a fluorescence-based cell–cell fusion assay, fusion pore
formation readily took place in cocultures of cells expressing the SHIV-9466.33 env glycoprotein with macaque T-lymphoid cells.INTRODUCTION
Genetic variability is the hallmark of human immuno-
deficiency virus type 1 (HIV-1). Diverse HIV-1 genotypes,
identified in the worldwide epidemic, have been classi-
fied into genetic subtypes (A through K) in group M, as
well as the highly divergent groups O and N (Robertson
et al., 2000). The env glycoprotein of HIV-1 governs sev-
eral viral properties (i.e., cell tropism, cytopathology, and
coreceptor usage) and is the major target for antiviral
immune responses. Thus, the high degree of sequence
variability of HIV-1 env presents a significant challenge
for vaccine development. HIV-1 subtype-A is prevalent in
Africa, which contains the majority of people living with
HIV-1 and AIDS in the world (Essex, 1999). HIV-1 sub-
type-E, identified as a unique subtype by genetic se-
quences in env, was first reported in Thailand (Mc-
Cutchan et al., 1992; Ou et al., 1992); this subtype has
also been found in Africa (Murphy et al., 1993; Nkengas-
ong et al., 1994). At present, subtype-E viruses are the
most prevalent strains in Thailand and neighboring na-
tions in Asia (Brown and McNeil, 1998). Subtype-E vi-
ruses have also entered other continents (Artenstein et
al., 1995; Bo¨ni et al., 1999; Brodine et al., 1995; Couturier189et al., 2000). The global epidemic of these and other viral
subtypes will impact the development and production of
HIV-1 vaccines (Brown and McNeil, 1998; Essex, 1999).
Additionally analysis of phenotypes of different HIV-1
subtypes may be important for understanding viral trans-
mission and pathogenesis (Hu et al., 1999)
The lack of an animal model for HIV-1 infection and
fatal immunodeficiency has hindered the elucidation of
determinants of transmission and pathogenesis of differ-
ent viral subtypes. Chimeric SHIV containing the env
gene of several HIV-1 subtype-B strains and one HIV-1
subtype-C strain replicated efficiently in vitro in macaque
cell cultures and established either transient or persis-
tent infection in macaques (Chen et al., 2000; Joag, 2000;
Nath et al., 2000). SHIV strains that infect, persist, and
cause immunodeficiency in macaques are important
challenge viruses for evaluating efficacy of vaccines
based on HIV-1 env glycoprotein immunogens. Our pre-
vious studies demonstrated that the chimeric SHIV-E-
CAR clone, containing the env gene of HIV-1CAR402 (sub-
type-E virus from the Central African Republic), readily
infected rhesus macaques through intravenous or intra-
vaginal inoculations (Himathongkham et al., 2000). In
contrast, another subtype-E chimera SHIV-9466.33, con-
taining the env gene of HIV-19466 (subtype-E virus fromTaken together, these results demonstrated that the block of
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also investigated the species tropism of two subtype-A
chimeric viruses, SHIV-A-170 and SHIV-A-Q23, contain-
ing the env gene of HIV-1SF170 and HIV-1Q23–17 (subtype-A
viruses from Rwanda and Kenya, respectively). Both chi-
meric viruses with subtype-A env genes were restricted
for replication in macaque cells. Detailed analysis of the
species restriction was performed on subtype-E chimeric
SHIV-9466.33; our studies revealed that replication was
blocked in macaque-T-lymphocyte cultures at an early
step, after fusion pore formation but before viral DNA
synthesis. Analysis of SHIV clones with the subtype-A or
subtype-E env genes described here in vitro and in
nonhuman primates can provide new insight on the
mechanism(s) of early events in viral replication.
RESULTS
Comparison of SHIV clones in humans and macaque
cells
To analyze HIV-1 subtype-A and subtype-E env-gene
functions, we compared SHIV clones constructed from
four divergent viruses. Selected for subtype-A viruses
were HIV-1SF170, a macrophage-tropic virus from an indi-
vidual in Rwanda, and HIV-1Q23–17, a non-syncytium-induc-
ing isolate from a nonsymptomatic individual in Kenya
(Cheng-Mayer et al., 1988; Poss et al., 1998). Additionally,
subtype-E viruses chosen for this study were HIV-19466, a
syncytium-inducing isolate from an AIDS patient in Thai-
land (Ichimura et al., 1994), and HIV-1CAR402, a syncytium-
inducing virus isolate from an AIDS patient in the Central
African Republic (Gao et al., 1996). All four chimeric
clones (SHIV-A-170, SHIV-A-Q23, SHIV-9466.33, and
SHIV-E-CAR) produced infectious virus after transfection
of 293T cells; infectivity was assessed by coculture of
transfected cells with human PBMC.
Replication properties of SHIV subtype-A and sub-
type-E clones were analyzed by infection of both human
and macaque PBMC cultures. The subtype-A chimeric
viruses, SHIV-A-Q23 (Fig. 1) and SHIV-A-170 (data not
shown), replicated in human lymphoid cells but not in
either macaque PBMC or Mm221 cell line. Both sub-
type-E SHIV clones, SHIV-E-CAR and SHIV-9466.33, rep-
FIG. 1. Replication of subtype-A SHIV-A-Q23 clone in human and macaque cells. SHIV-A-Q23 viral production, measured by ELISA for SIV p27
antigen, was analyzed in (A) human cells (PM-1) and (B) macaque cells (Mm221 and macaque PBMC) at 0, 4, 8, 10, 13, and 17 days postinfection.
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licated efficiently in human lymphoid cells; however,
SHIV-9466.33 replication in macaque lymphoid cells was
restricted (Fig. 2). Further studies to define region of env
that governed this species tropism were focused on the
subtype-E SHIV-9466.33 clone.
To determine whether env gp120 or gp41 of HIV-19466
controls restriction of SHIV-9466.33 in macaque cells,
replication of SHIV-9466su was analyzed in human and
macaque cells (Fig. 2). SHIV-9466.33, SHIV-9466su, and
SHIV-E-CAR replicated efficiently in human PBMC cul-
tures and in PM-1 cells (Fig. 2A). In contrast, both SHIV-
9466su and SHIV-9466.33 did not yield detectable virus
in either primary macaque cells or the Mm221 line,
whereas SHIV-E-CAR replicated efficiently in these cells
(Fig. 2B). These results indicated that gp120 of the
HIV-19466 (subtype-E) isolate played a critical role in re-
stricting replication of the SHIV clones containing sub-
type-E env sequences of HIV-19466 in macaque cells.
To identify the region(s) in gp120 of the HIV-19466 re-
sponsible for restricted replication in macaque cells,
intragenic env recombinant was constructed from env of
HIV-19466 and HIV-1CAR402. The first SHIV clone containing
an intragenic env gene, SHIV-E-R1, was not infectious.
The reciprocal recombinant clone, SHIV-E-R2 clone, rep-
licated efficiently in human PBMC and PM-1 cells (Fig.
3A). Interestingly, the SHIV-E-R2 readily infected both
Mm221 line and macaque PBMC (Fig. 3B). These find-
ings suggested that the sequence encompassing V1/V2
region of HIV-19466 was responsible for the restriction of
SHIV-9466.33 replication in macaque cells.
Analysis of the block to replication of SHIV-9466.33 in
macaque cells
Viral DNA synthesis. To determine whether the block
to replication was in the early or late phase of the viral
FIG. 2. Replication of SHIV-9466su in human and macaque cells. SHIV-9466.33, SHIV-9466su, and SHIV-E-CAR viral production, measured by ELISA for SIV p27
antigen, was analyzed in (A) human cells (PM-1 and human PBMC) and (B) macaque cells (Mm221 and macaque PBMC) at 0, 4, 8, 10, and 13 days postinfection.
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life cycle, the level of viral DNA was analyzed in ma-
caque cells inoculated with SHIV-9466.33. After inocula-
tion of macaque PBMC cultures with a cell-free prepa-
ration of SHIV-9466.33, whole-cell DNA was isolated at 0,
6, 12, and 24 h after infection, and viral DNA levels were
determined in a semiquantitative PCR amplification sys-
tem. Complete proviral DNA and strong stop viral DNA
were monitored by measuring the amount of the 475 or
295 bp DNA, respectively, produced by PCR amplification
with primers specific for SIV sequences (Figs. 4A and
4C). After infection with SHIV-9466.33, viral DNA was
barely detected in macaque PBMC (Figs. 4B and 4D).
SHIV-9466.33-infected human PBMC and SHIV-SF33-in-
fected macaque PBMC served as positive controls for
detection of synthesized viral DNA. Analysis of viral DNA
in cultures treated with the reverse transcriptase inhibi-
tor azidothymidine (AZT) was performed to ensure that
viral DNA detected in these studies was newly synthe-
sized and not carried over in virions. Taken together,
these results demonstrated that the block to SHIV-
9466.33 replication in rhesus macaque PBMC was at the
early phase of viral infection, involving a step(s) at/or
prior to reverse transcription.
Fusion. To examine further whether the block of SHIV-
9466.33 infection in macaque lymphocytes took place at
the step of fusion entry, we adopted a fluorescent dye
transfer system to detect cell–cell fusion mediated by the
env glycoprotein. This system, described under Materi-
als and Methods, is based on redistribution of cytoplas-
mic fluorescent dyes between env-expressing 293T cells
and macaque CD4 T-lymphoid cells (Mm221 cells). Ex-
pression of 9466.33 env on transfected 293T cells was
detected by immunofluorescence microscopy using
monoclonal antibody to HIV-1 gp120 (data not shown).
Env-expressing 293T cells labeled with the CMTMR dye
had high viability (96%) and exhibited an evenly distrib-
uted diffuse red fluorescence. Mm221 cells labeled with
the CMFDA dye also showed high viability (98%) and a
bright green fluorescence. Figures 5A–5C, 5D–5F, and
5G–5I contain panels of images (bright field, red fluores-
cence, and green fluorescence) obtained 8 h after cocul-
turing CMFDA-labeled macaque CD4 T-lymphocyte
Mm221 cells and CMTMR-labeled 293T cells expressing
the env gene of HIV-1CAR402, SHIV-9466.33, or SHIV-E-R2,
respectively. The lymphocytes adhered to the env-ex-
pressing 293T cells and many retained a typical spheri-
FIG. 3. SHIV-R2 replication in human and macaque cells. SHIV-E-R2 and SHIV-E-CAR viral production, measured by ELISA for SIV p27 antigen, was
analyzed in (A) human cells (PM-1) and (B) macaque cells (Mm221 and macaque PBMC) at 0, 4, 7, 11, 14, 17, and 21 days postinfection.
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cal morphology with a discreet, bright green fluores-
cence. When viewed under red fluorescence, these cells
frequently appeared as dark “shadows” on the underlying
red 293T cells. The white arrow indicates an example of
such a cell. Other lymphocytes in these cocultures did
not retain their rounded morphology and the green fluo-
rescence appeared to have spread, forming larger areas
of diffuse green fluorescence. These areas of diffuse
green fluorescence were only seen in cell clusters that
consisted of both macaque lymphocytes and 293T cells.
FIG. 4. PCR analysis of SHIV-9466.33 DNA in rhesus macaque PBMC. (A and C) The PCR primer pairs (32P-labeled) specific for LTR/gag region of
SIVmac239, S265, and S267, and the R/U5 region, S265 and S109, detect a late (475 bp) and an early (295 bp) reverse transcription product. (B and D)
Viral DNA was measured in SHIV-9466.33-infected macaque PBMC, in the absence or presence of 10 M AZT, at 0, 6, 12, and 24 h after infection.
SHIV-9466.33-infected human PBMC and SHIV-SF33-infected macaque PBMC served as positive controls. A primer pair specific for the human
-globin was included in all reactions to serve as control. After PCR amplification, DNA products were analyzed by electrophoresis on polyacrylamide
gels and visualized by autoradiography of dried gels.
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The diffuse green fluorescence frequently colocalized
with the red fluorescence associated with the 293T cells.
Arrowheads in Fig. 5 indicate examples of areas where
there appears to be colocalization of green and red
fluorescence. Panels J–L in Fig. 5 show controls, includ-
ing coculture of macaque lymphocytes incubated with
mock-transfected 293T cells. In these control cocultures,
the CMFDA-labeled lymphocytes maintained a uniform,
rounded morphology and showed little adherence to the
293T cells. Larger areas of diffuse green fluorescence
that colocalized with the red fluorescence were not de-
tected.
This fluorescence microscopy procedure to measure
env-mediated dye-redistribution was used for rapid
screening of large numbers of samples and suggested
that fusion pore formation was taking place in the env-
expressing cocultures but not in the control (mock-trans-
fected) coculture. To ensure that the colocalization of
green and red fluorescence was due to fusion process
and was not due to overlap of cells, selected cocultures
were also examined by confocal microscopy. Figure 6
shows one optical section (from a stack of 40) obtained
from analysis of a typical CMFDA-labeled Mm221 cell/
CMTMR-labeled 9466.33env-expressing 293T cell cocul-
ture; two cell clusters are apparent. The fluorescence
intensity profile corresponding to the region along the
white arrow, drawn on the leftmost cell cluster, is also
shown in Fig. 6. For this cell cluster, colocalization of
both green and red fluorescence, consistent with cell–
cell fusion, is clearly observed. Similar evidence of green
and red fluorescence colocalization was found upon
examining other env-expressing 293T cells in this same
experiment (data not shown). Confocal imaging of the
cell cluster on the right in Fig. 6 showed no evidence of
green/red fluorescence colocalization despite the fact
that the CMFDA-labeled cell is adherent to the CMTMR-
labeled cell colony. This observation provides an internal
control that argues against the idea that colocalization of
the fluorescent dyes results from dye leakage and dye
re-uptake. These results indicate that SHIV-9466.33 rep-
lication was restricted in macaque cells at an early step,
after fusion pore formation of virion and cell surface
membranes.
DISCUSSION
Studies on several HIV-1 subtype-B isolates showed
that the env glycoprotein of this virus plays a major role
in virion entry of CD4 T-lymphocytes and influences cell
tropism (Luciw, 1996; Weiss, 1994). Previous work dem-
onstrated that the env glycoprotein of HIV-1 subtype-B
isolates from North America and Europe is not respon-
sible for the block to infection of macaque cells (Hima-
thongkham and Luciw, 1996; Shibata et al., 1995). Here,
we demonstrated that the env gene of HIV-19466, a sub-
type-E virus from Thailand, was a major factor that re-
stricted replication in macaque cells. Two additional chi-
meric clones, SHIV-A-170 and SHIV-A-Q23 containing
different HIV-1 subtype-A env genes, were also restricted
in macaque lymphoid cells (Table 1). An R5-tropic chi-
meric virus, SHIVCHN19, containing a subtype-C env gene
from HIV-1CHN from China, did not replicate in vitro in
rhesus macaque lymphocytes but replicated in lympho-
cytes from pig-tailed macaques (Chen et al., 2000). It
remains to be determined whether the subtype-A and
subtype-E SHIV clones infect and replicate in pig-tailed
macaque cells.
Biochemical analysis revealed that an early step(s)
prior to viral DNA synthesis was blocked in replication of
the SHIV-9466.33 clone in macaque cells. The colocal-
ization of fluorescent dyes that was observed by fluores-
cence microscopy and confocal microscopy when 293T
TABLE 1
Summary of Human and Macaque Tropisms of SHIV Containing







PM-1 PBMC Mm221 PBMC
B SHIV-SF33    
E SHIV-9466.33    
E SHIV-9466su    
E SHIV-E-CAR    
E SHIV-E-R2    
A SHIV-A-170    
A SHIV-A-Q23    
FIG. 5. Analysis of fluorescence dye-redistribution in cocultures of env expressing 293T cells and Mm221 cells. Envelope-expressing 293T cells were
labeled with 2 M CMTMR dye and lymphocytic Mm221 cells were labeled with 2 M CMFDA dye as described under Materials and Methods. The cells
were cocultured for 8 h and then examined in a Nikon Eclipse E800 epifluorescencemicroscope equipped with a CCD camera. For each field of view, images
corresponding to bright field, CMTMR dye (red fluorescence), and CMFDA dye (green fluorescence) were captured directly into Photoshop. (A–C) CAR-env;
(D–F) 9466.33-env; (G–I) R2-env; (J–L) mock-transfected 293T cells. The arrow indicates a lymphocyte that shows no redistribution of fluorescence.
Arrowheads point to examples where green and red fluorescence appears to colocalize. The horizontal lines indicate 50-m markers. The images in A–I
were obtained with a 40 objective and that in J–L with a 20 objective. These experiments were performed at least three times with similar results.
FIG. 6. Analysis of fluorescence dye colocalization by confocal microscopy. 293T cells expressing env glycoprotein of SHIV-9466.33 were labeled with
2 MCMTMR dye (red fluorescence) and macaque lymphocytic Mm221 cells were labeled with 2 MCMFDA dye (green fluorescence) as described under
Materials and Methods. The cells were cocultured for 8 h and then examined by confocal microscopy to obtain a stack of 0.9-m optical sections. The
photomicrograph shows a representative optical section. The graph shows the green/red fluorescence intensities along the white arrow drawn on the
micrograph. Similar results were found using 293T cells expressing other HIV-1 env glycoproteins.
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(human) cells expressing env gene of SHIV-9466.33 were
cocultured with macaque lymphoid cells is consistent
with cell–cell fusion pore formation. Taken together, these
findings point to a restriction of SHIV-9466.33 at a step
between fusion entry and initiation of viral DNA synthesis.
Experiments were conducted to determine whether a
specific domain in the env glycoprotein of subtype-E
HIV-19466 controlled this restricted tropism. Several env
intragenic recombinants were constructed between the
gp120 region of the env genes of HIV-19466 and HIV-1CAR402.
Most of the SHIV proviral clones with these intragenic
recombinant env genes were not infectious in human
lymphoid cells (Fig. 7 and data not shown). However, one
chimeric proviral clone, SHIV-E-R2, was infectious in
both human and macaque lymphoid cells. This finding
indicated that the region encompassing the V1/V2 region
of HIV-1CAR402env was important for allowing replication in
macaque cells. The V1/V2 region of the env glycoprotein
influences coreceptor interaction as well as cell tropism,
cytopathicity, and sensitivity to neutralizing antibodies
(Hoffman and Doms, 1999). Our results indicated that the
V1/V2 region plays an important role in virion entry. In the
model proposed above, it is possible that the V1/V2
region of HIV-1CAR402env gp120 binds a putative cellular
protein, which is essential for infection of macaque cells
at the uncoating step in viral replication.
SHIV clones constructed from env genes of HIV-1
subtype-B have proven useful for assessing viral deter-
FIG. 7. Structures and viral recovery in human PBMC of chimeric SHIV clones containing env region sequences from HIV-1 subtype-A or subtype-E
isolates. The SHIV-SF33 chimera is shown at the top. Shaded boxes represent sequences derived from the HIV-1SF33 (subtype-B) clone. Boxes with
diagonal lines represent sequences derived from the HIV-19466 (Thai subtype-E) isolate; solid gray boxes represent sequences derived from the
HIV-1CAR402 (African subtype-E) isolate. Boxes with horizontal lines represent sequences derived from HIV-1SF170 (Rwanda subtype-A); boxes with grid
lines represent sequences derived from the HIV-1Q23–17 (Kenya subtype-A). The surface (SU) gp120 and transmembrane (TM) gp41 regions of the
envelope glycoproteins are shown.
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minants of pathogenesis and transmission (Buch et al.,
2000; Karlsson et al., 1997; Lu et al., 1998; Shibata et al.,
1997). Our article indicates that further studies will be
necessary to reliably construct SHIV clones, containing
env genes of non-subtype-B HIV-1 isolates that replicate
in macaque cells. The availability of nonhuman primate
model susceptible to infection with the subtype-E SHIV
chimeric virus will facilitate the development of HIV-1
vaccines targeting for Thailand and neighboring coun-
tries in Asia.
MATERIALS AND METHODS
Construction of SHIV chimera and env expression
vectors
The cloning strategy for constructing pSHIV-SF33,
pSHIV-9466.33, and pSHIV-E-CAR chimeras was de-
scribed elsewhere (Himathongkham et al., 2000; Klinger
et al., 1998; Luciw et al., 1999). Clones pSHIV-A-170 and
pSHIV-A-Q23 were also constructed by using the same
strategy as mentioned above. Plasmid pSHIV-9466su
was constructed by replacing gp41 of pSHIV-9466.33
with the counterpart region of HIV-1SF33. Overlapping PCR
amplification was used to generate sequences at the
junction of HIV-19466 gp120/HIV-1SF33 gp41 from MunI site
to AvrII site (343 bp). Two PCR primer pairs were de-
signed as shown. Primer SU1: 5GGAGGAAATATAAAG-
GACAATTGGAGAAGTG3, primer SU2: 5TATCACTC-
CCACTGCTCTTTTTTCTCTCTGCACCACTCTTCTC3,
primer SU3: 5 AGAGAGAAAAAAGAGCAGTGGGAGT-
GATAGGAGCTATGTTCC 3, primer SU4: CCCCAAATC-
CCTAGGAGCTGTTGATCTCTTAGGTATC 3. Underlined
nucleotide residues are HIV-19466 sequences. The first
primer pair (SU1 and SU2) and the second pair (SU3 and
SU4) were used to amplify 115 and 267 bp DNA frag-
ments from HIV-19466 and HIV-1SF33, respectively. PCR
products were pooled and used as target for the next
PCR amplification by using primers SU1 and SU4 to
generate a 343-bp DNA fragment. The DNA fragment
was digested with MunI and AvrII and then cloned into
pSHIV-9466.33 to obtain pSHIV-9466su. Construction of
pSHIV-E-R1 and pSHIV-E-R2 was based on standard
cloning methods using unique restriction sites (BsaBI
and XhoI) available in pSHIV-9466.33 and pSHIV-E-CAR.
For pSHIV-E-R1, we replaced the DNA fragment encom-
passing V3V4V5 regions of gp120 and gp41 of pSHIV-E-
CAR with the counterpart region of pSHIV-9466.33. Plas-
mid pSHIV-E-R2 was constructed as a reciprocal clone of
pSHIV-E-R1 (Fig. 7). All constructs were verified by DNA
sequencing. Accession number for the env gene of
HIV-1SF170, kindly provided by C. Cheng-Mayer (Aaron
Diamond Center, NY), is M66533; accession number for
HIV-1Q23–17, kindly provide by J. Overbaugh (University of
Washington, WA), is AF004885.
The gp160 env genes of SHIV-E-CAR, SHIV-9466.33,
and SHIV-E-R2 were amplified by PCR and individually
cloned into the env expression plasmid, pND14, which
contains the cytomegalovirus immediate early gene pro-
moter (Luciw, 1999). Plasmids were transfected into 293T
cells and the time for optimal expression was deter-
mined by immunofluorescence microscopy and Western
blot analyses of the transfected cells. Mouse monoclonal
anti-HIV-1 gp120 antibody was generously provided by
P. L. Earl, NIAID, NIH.
Cell culture
The human embryonic kidney 293T cells were cultured
in DMEM media supplemented with 10% fetal bovine
serum, 100 u/ml penicillin, 100 g/ml streptomycin, and 1
mM L-glutamine. PM-1 cells, a human T-cell line, was
obtained from Robert Gallo (University of Maryland, MD)
and cultured in RPMI 1640 medium supplemented with
10% fetal bovine serum, 100 u/ml penicillin, 100 g/ml
streptomycin, and 1 mM L-glutamine. The macaque T cell
line Mm221 was obtained from Ron Desrosiers (New
England Primate Research Center, Southboro, MA) (Al-
exander et al., 1997) and cultured in RPMI 1640 medium
supplemented with 20% fetal calf serum and recombi-
nant human interleukin-2 (IL-2) at 75 u/ml (AIDS Re-
search and Reference Reagent Program, NIH, Bethesda,
MD; Chiron Corp., Emeryville, CA), 2 -mercaptoethanol,
and 25 mM HEPES buffer. Culture medium for human
and rhesus macaque PBMC was complete RPMI 1640
medium supplemented with recombinant human IL-2 at
50 u/ml. Human PBMC from a healthy, HIV seronegative
donor were prepared by Ficoll–Hypaque density centrif-
ugation of heparinized blood resuspended in the culture
medium described above and stimulated with 5 g/ml
phytohemagglutinin for 3 days. PBMC from rhesus ma-
caques were also prepared by the same procedure ex-
cept these cells were stimulated with 0.5 g/ml Staphy-
lococcus enterotoxin A (Toxin Technology, Inc., Sarasota,
FL).
Transfection of cloned proviral DNA to recover virus
To recover virus from cloned DNA plasmids, 10 g
pVP-1, containing the 5 half of the pathogenic clone
SIVmac239, was digested with SphI and ligated to 10 g of
the 3 half of the SHIV genome, which also linearized
with SphI (Klinger et al., 1998). These 3 half-plasmids are
pSHIV-E-CAR, pSHIV-9466.33, pSHIV-9466su, pSHIV-E-
R1, pSHIV-E-R2, pSHIV-A-170, and pSHIV-A-Q23. The
SphI-digested DNA samples, representing the 5 and 3
halves of proviral DNA, were mixed, ligated with T4 DNA
ligase, and transfected into 293T cells by lipofection. Two
days after transfection, 293T cells were cocultivated with
human PBMC and cultured for 10–20 days. Supernatants
from these cocultures were clarified by low-speed cen-
trifugation and filtered through 0.2-m filter and used for
virus stocks. The titer of these stocks was determined by
end-point dilution on PM-1 cells in microtiter plates.
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Amounts of virus production from these stocks were
determined by measuring SIV p27 core protein by ELISA
(Coulter, Hialeah, FL).
Virus assay
After the 3-day stimulation period, cultures of human
and rhesus macaque PBMC were inoculated with the
viruses (SHIV-A-Q23, SHIV-A-170, SHIV-9466.33, pSHIV-
9466su, SHIV-E-R2, or SHIV-E-CAR) at 0.001 TCID50 per
cell and maintained in complete RPMI 1640 medium
supplemented with 50 u/ml IL-2. PM-1 and Mm221 cell
lines were also exposed to the same amount of viruses.
Culture supernatants were collected twice a week after
infection and analyzed for virus production by measuring
p27 SIV core protein by ELISA (Coulter).
Analysis of viral DNA by PCR amplification
PCR analysis was done to determine SHIV-9466.33
DNA in human and rhesus macaque PBMC. Primer pairs
specific for the R/U5 region, S265 and S109, and the
LTR/gag region of SIVmac239, S265 and S267, were used to
detect an early (295 bp) and a late (475 bp) reverse
transcription product, respectively. The sequence of
S109 is 5 GATTTTCCTGCTTCGGTTTCCC 3, and other
primer sequences are cited in Zou and Luciw, 1996.
Stimulated rhesus macaque PBMC and human PBMC, in
the absence or presence of 10 M AZT, were exposed to
SHIV-9466.33 and SHIV-SF33 at 0.25 pg per cell and
incubated at 37°C for 1.5 h. After absorption, cells were
washed three times and maintained in culture medium
supplemented with recombinant IL-2. Cell samples were
collected at 0, 6, 12, and 24 h after infection and cell
pellets were lysed in buffer containing 10 mM Tris (pH
8.3), 0.45% NP-40, 0.45% Tween 20, and 50 g/ml pro-
teinase K. To control for the amount of infected cell DNA
substrate for PCR amplification, a primer pair (PC03 and
PC04) specific for the human -globin gene was in-
cluded in all reactions (Saiki et al., 1988). For detection of
PCR amplification products, one primer from each pair of
primers was end-labeled with [32P]ATP by T4-polynucle-
otide kinase. Buffer for PCR amplification containing 1.5
mM MgCl2, 50 mM KCl, 100 mM Tris pH 8.3 was mixed to
0.2 mM dNTP per nucleotide, 2 u Taq polymerase (Per-
kin–Elmer Cetus), and 20 pmol of the appropriate primers
in a total volume of 50 l. The PCR mixtures were
subjected to 30 cycles of amplification by Thermal Cycler
(Perkin–Elmer Cetus) at 94°C for 1.5 min and 72°C for 3
min, and extension at 72°C for 7 min. After the PCR
amplification, DNA products were analyzed by electro-
phoresis on polyacrylamide gels and visualized by auto-
radiography of dried gels.
Fusion assay
Cell–cell fusion was assayed by using a fluorescence
dye transfer system modified from Mun˜oz-Barroso et al.
(1999). Briefly, 293T cells were transfected with 2 g
pND14-CAR, pND14–9466.33, pND14-R2, or pND14 (vec-
tor alone) by FuGENE-6 (Roche Molecular Biochemical,
IN) in 100-mm culture dishes. Envelope-expressing 293T
cells were replated at 6 h posttransfection onto cover-
slips in growth medium at 37°C. At 12 h posttransfection,
the cells were labeled with 2 M 5-(and-6)-(((4-chloro-
methyl) benzoyl) amino) tetramethylrhodamine (CMTMR:
MW 554.04, ex/em 540/566 nm, Molecular Probes) for 30
min at 37°C. Subsequently, CD4 rhesus macaque T-
lymphocyte Mm221 cells were labeled with 2 M 5-chlo-
romethylfluorescein diacetate (CMFDA: MW 484.86,
ex/em 492/516, Molecular Probes) for 30 min at 37°C.
The labeled cells were washed, resuspended in fresh
medium, incubated for 30 min at 37°C, washed twice,
and resuspended in growth medium. CMFDA-labeled
macaque CD4 T-lymphocyte Mm221 cells and CMTMR-
labeled env-expressing 293T cells were cocultured at a
ratio of 10:1. After 8 h of cocultivation, the cells were
examined using a Nikon Eclipse E800 epifluorescence
microscope equipped with a CCD camera. CMTMR was
visualized using an EF-4 G-2E/C TRITC filter cube
(EX528–553; EM600–660). CMFDA was visualized using
an EF-4 B-2E filter cube (EX450–490; EM520–560). Cells
were also viewed under bright field to assess overlap-
ping cells. For each experimental condition, an entire
coverslip was examined using the 10 objective to as-
sess the distribution of green and red fluorescence.
Representative fields were then captured using the 20
or 40 objective. For each field, three images (bright
field, CMTMR fluorescence, and CMFDA fluorescence)
were captured directly into Photoshop. To confirm colo-
calization of red and green fluorescence within the same
cell, the cocultures were also examined using a Zeiss
LSM 510 laser scanning confocal microscope. Using a
40 oil objective, a stack of images with a step size of
0.9 m and an optical section thickness of 0.9 m was
collected.
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